Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|March 27, 2026
Combined use of serum KL-6 and respiratory functional parameters for identifying fibrotic lung damage in SARS-CoV-2-induced interstitial pneumoniaMiriana D'Alessandro, Irene Paggi, Giusy Montuori, et al.
Frontiers in Pharmacology|March 21, 2022
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping ReviewLaura Bergantini, Alessandro Mainardi, Miriana d'Alessandro, et al.
Immunity, Inflammation and Disease|January 14, 2025
Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post-COVID-19 Pulmonary Fibrosis and Idiopathic Pulmonary FibrosisSara Gangi, Laura Bergantini, Irene Paggi, et al.
Journal of Clinical Medicine|October 16, 2025
From Prognostic Marker to Therapeutic Agent: The Role of Nitric Oxide in Lung CancerTommaso Pianigiani, Akter Dilroba, Asia Fanella, et al.
Biomolecules|May 28, 2022
Oxygen Therapy during Exercise in Patients with Interstitial Lung DiseasesMagda Viani, Vittoria Ventura, Francesco Bianchi, et al.
Pulmonology|June 22, 2026
Adhesion molecules and T cell imbalance in severe eosinophilic asthma: Insights from anti-IL-5R treatmentLaura Bergantini, Irene Paggi, Tommaso Pianigiani, et al.
Nitric Oxide : Biology and Chemistry|May 6, 2019
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosisPaolo Cameli, Laura Bergantini, Martina Salvini, et al.
Panminerva Medica|April 16, 2020
Serum CD59: a novel biomarker of idiopathic pulmonary fibrosis?Paolo Cameli, Laura Bergantini, Miriana D'Alessandro, et al.
Antioxidants (Basel, Switzerland)|September 28, 2021
Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal StudyPaolo Cameli, Elena Bargagli, Laura Bergantini, et al.
Pageof 13